CURE had the privilege of attending the Hairy Cell Leukemia Foundation 2025 Conference in Bologna, Italy, where medical experts gathered to discuss advances in research, treatment ...

While October promotes awareness through campaigns, ribbons and fundraising, survivors report a more complex reality. Breast cancer survivor Maureen Green described the month as a reminder of the ...

PhD in clinical psychology. She is a senior psychologist, director of Interprofessional Education and director of the Young Adult Program (YAP) in the Department of Supportive Oncology at Dana-Farber ...

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old. A new book aims to educated young ...

“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

Caregivers must respect the autonomy of adult patients, balancing support with allowing them to lead their own cancer journey ...

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable. This guide is designed to provide newly diagnosed patients with the necessary information ...

Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...